Comparison of Single and Multiple-dose Methotrexate Therapy for Ectopic Pregnancy

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Pregnancy, Ectopic Clinical Trial

Official title:
Comparison of Single and Multiple-dose Methotrexate Therapy for Ectopic Pregnancy: a Clinical Trail

Status Completed

Clinical Trial Summary

The aim of this study was to compare single dose Methotrexate (MTX) to multiple dose MTX.

n/a

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

NCT number	NCT01662167
Study type	Interventional
Source	Hormozgan University of Medical Sciences
Contact
Status	Completed
Phase	Phase 4
Start date	January 2008
Completion date	December 2011

See also
Status	Clinical Trial	Phase
Completed	`NCT02973230` - Serum VEGF as a Tubal Pregnancy Marker	N/A
Completed	`NCT03327688` - Point-of-care Ultrasound in Finland	N/A
Completed	`NCT05446012` - Relationship Between Ectopic Pregnancy and Thyroid Disorders
Completed	`NCT02831556` - Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Active, not recruiting	`NCT03461835` - Management of Pregnancies of Unknown Location (PUL)	N/A
Completed	`NCT03670784` - Occurrence and Trend of Pregnancies Growing Outside the Womb (Ectopic Pregnancy) 2009-2018. A Study on a Defined Group of Persons